Cyclandelate in the prophylaxis of migraine: A randomized, parallel, double-blind study in comparison with placebo and propranolol

Cephalalgia

Volumn 16, Issue 6, 1996, Pages 441-447

  Diener, H C ^a   Foh M ^e   Iaccarino, C ^f   Wessely, P ^b   Isler, H ^c   Strenge, H ^d   Fischer, M ^h   Wedekind, W ⁱ   Taneri, Z ^g  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF ZURICH   (Switzerland)

^d UNIVERSITY OF KIEL   (Germany)

^e Municipal Hospital   (Germany)

^f Migraine Clinic ^*

^g Institute for Numerical Statistics   (Germany)

^h Medical Department of 3M Medica   (Germany)

ⁱ 3M Deutschland GmbH   (Germany)

Author keywords

Cyclandelate; Double blind; Placebo; Prophylaxis of migraine; Propranolol; Tolerability

Indexed keywords

CYCLANDELATE; PLACEBO; PROPRANOLOL;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; SLEEP DISORDER; STOMACH PAIN;

ADULT; CYCLANDELATE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; PAIN MEASUREMENT; PROPRANOLOL; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 0029797624     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-2982.1996.1606441.x     Document Type: Article

References (20)

1. Al-Qassab HK, Findley LJ. Comparison of propranolol LA 80 mg and propranolol LA 160 mg in migraine prophylaxis: a placebo controlled study. Headache 1993;33:128-31
2. Cortelli P, Sacquegna T, Albani F, Baldrati A, D'Allessandro R, Baruzzi A, Lugaresi E. Propranolol plasma levels and relief of migraine. Arch Neurol 1985;45:46-8
3. Diamond S, Medina JL. Double blind study of propranolol for migraine prophylaxis. Headache 1976;16:24-7
4. Johnson RH, Hornabrook RW, Lambie DG. Comparison of mefenamic acid and propranolol with placebo in migraine prophylaxis. Acta Neurol Scand 1986;73:490-2
5. Nadelmann JW, Stevens J, Saper JR. Propranolol in the prophylaxis of migraine. Headache 1986;26:175-82
6. Havanka-Kanniainen H, Hokkanen E, Myllylä VV. Long-acting propranolol in the prophylaxis of migraine. Comparison of the daily doses of 80 mg and 160 mg. Headache 1988;28:607-11
7. Holroyd KA, Penzien DB, Cordingly GE. Propranolol in the management of recurrent migraine: a meta-analytic review. Headache 1991;31:333-40
8. Perrier ML, Scatton B, Benavides J. Dihydropyridine- and omega-conotoxin resistant, neomycin-sensitive calcium channels mediate the depolarization-induced increase in internal calcium levels in cortical slices from immature rat brain. J rharmacol Experimen Ther 1992;261:324-30
9. van Nueten JM. Comparative bioassay of vasoactive drugs using isolated perfused rabbit arteries. Eur J Pharmacol 1969;6:286-93
10. ++-induced muscle contraction. J Pharm Pharmacol 1971;23:107-10
11. van den Hoven WE, Hall DWR. Inhibition of human platelet functions by cyclandelate. Drugs 1987;33 Suppl 2:41-52
12. van den Hoven WE, Hall DWR. Inhibition of human platelet aggregation by cyclandelate. Br J Clin Pract 1984 Suppl 38;6:34-7
13. ++-translocation in human platelets. Drugs 1987; 33 Suppl 2:53-9
14. Gotti B, Benavides J, MacKenzie ET, Scatton B. The pharmacotherapy of focal cortical ischaemia in the mouse. Brain Res 1990;522:290-307
15. Nappi G, Sandrini G, Savoini G, Cavallini A, de Rysky C, Micieli G. Comparative efficacy of cydandelate versus flunarizine in the prophylaxis of migraine. Drugs 1987;33 Suppl 2:103-9
16. Mastrosimone F, Iaccarino C, de Caterina G. Efficacy and tolerance of cyclandelate versus pizotifen in the prophylaxis of migraine. J Med 1992;23:1-16
17. Gerber WD, Schellenberg R, Thom M, Haufe C, Bölsche F, Wedekind W, Niederberger U, Soyka D. Cyclandelate versus propranolol in the prophylaxis of migraine. A double-blind study. Funct Neurol 1995;1:27-35
18. Haag G, Mastrosimone F, Iaccarino C, Müller MJ. Langzeitwirksamkeit und Nebenwirkungen verschiedener Migräneprophylaktika - eine retrospektive Analyse. Der Schmerz 1994;8:162-9
19. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neurologias and facial pain. Cephalalgia 1988;8 Suppl 7:1-93
20. International Headache Society Committee on Clinical Trials in Migraine. Guidelines for controlled trials of drugs in migraine. Cephalalgia 1991;111-12